DBV Technologies reported $15.69M in Trade Debtors for its fiscal quarter ending in June of 2025.




Trade Debtors Change Date
Acadia Pharmaceuticals USD 119.69M 5.97M Jun/2025
Alnylam Pharmaceuticals USD 567.11M 149.08M Jun/2025
Amarin USD 106.73M 15.54M Mar/2025
BioMarin Pharmaceutical USD 855.85M 116.68M Jun/2025
DBV Technologies USD 15.69M 3.38M Jun/2025
Halozyme Therapeutics USD 316.34M 11.72M Jun/2025
Incyte USD 842.89M 19.76M Jun/2025
Insmed USD 55.03M 7.29M Jun/2025
Ionis Pharmaceuticals USD 52.58M 12.87M Jun/2025
Neurocrine Biosciences USD 595.7M 79.7M Jun/2025
PTC Therapeutics USD 196.13M 14.36M Jun/2025
Sarepta Therapeutics USD 609.6M 114.93M Jun/2025
Ultragenyx Pharmaceutical USD 124.46M 25.62M Jun/2025
United Therapeutics USD 379.3M 57.3M Jun/2025